IMMEDICA UK LIMITED
Get an alert when IMMEDICA UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-05 (in 5mo)
Last made up 2025-09-21
Watchouts
Cash
£7M
+100.1% vs 2023
Net assets
-£15M
-189.9% vs 2023
Employees
41
+7.9% vs 2023
Profit before tax
-£10M
+45.5% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
3 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Name history
Renamed 2 times since incorporation — the current trading name was adopted 2026-02-09
- IMMEDICA UK LIMITED 2026-02-09 → present
- NEUROCRINE UK LIMITED 2024-10-21 → 2026-02-09
- DIURNAL LIMITED 2004-09-21 → 2024-10-21
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £12,885,000 | £16,553,000 | |
| Operating profit | -£17,448,000 | -£8,203,000 | |
| Profit before tax | -£17,664,000 | -£9,629,000 | |
| Net profit | -£17,418,000 | -£9,714,000 | |
| Cash | £3,262,000 | £6,527,000 | |
| Total assets less current liabilities | — | — | |
| Net assets | -£5,116,000 | -£14,830,000 | |
| Equity | -£5,116,000 | -£14,830,000 | |
| Average employees | 38 | 41 | |
| Wages | £4,817,000 | £5,703,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -135.4% | -49.6% | |
| Net margin | -135.2% | -58.7% | |
| Gearing (liabilities / total assets) | 125.7% | 158.2% | |
| Current ratio | 0.78x | 0.61x | |
| Interest cover | -68.96x | -5.38x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Haines Watts Wales LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company is reliant on the continued financial support of its ultimate parent, Neurocrine Biosciences, Inc., which has indicated its intention to continue to make available such funds as are needed by the Company, and that it does not intend to seek repayment of the amounts due, for at least the next 12 months following approval of these financial statements, and thereafter for the foreseeable future.”
Group structure
- IMMEDICA UK LIMITED · parent
- Neurocrine Netherlands B.V. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 28 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-12-14 | — | — |
| BELL, Mark John Paul | Director | 2026-01-21 | Nov 1974 | British |
| FLECK, Nina Magdalena | Director | 2026-01-21 | Sep 1976 | Swedish |
| OWENS, Benjamin Michael Joseph, Dr | Director | 2026-01-21 | Mar 1985 | British |
Show 28 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ARDILL, Ian Leslie | Secretary | 2015-12-17 | 2017-01-13 |
| BUNGAY, Richard Edward | Secretary | 2017-01-13 | 2022-11-10 |
| MCMASTER, Ross Alexander | Secretary | 2004-09-29 | 2015-12-17 |
| YORK PLACE COMPANY SECRETARIES LIMITED | Corporate Nominee Secretary | 2004-09-21 | 2004-09-29 |
| ABERNETHY, Matthew Charles | Director | 2022-11-01 | 2026-01-21 |
| ALLEN, Peter Vance | Director | 2015-07-01 | 2016-03-23 |
| ARDILL, Ian Leslie | Director | 2015-04-22 | 2017-01-13 |
| BAYNES, David Graham | Director | 2005-10-06 | 2014-10-29 |
| BOVERIE, Julie Odette | Director | 2023-04-19 | 2026-01-21 |
| BRYETT, Kevin Alan | Director | 2007-01-17 | 2015-04-22 |
| BUNGAY, Richard Edward | Director | 2017-01-18 | 2022-11-10 |
| CATTON, David John, Mr. | Director | 2004-09-29 | 2005-10-06 |
| GODDARD, John Geoffrey | Director | 2015-11-06 | 2016-03-23 |
| GORMAN, Kevin Charles | Director | 2022-11-01 | 2023-08-30 |
| GRANT, Peter Leonard, Dr | Director | 2004-09-29 | 2014-10-29 |
| JONES, Stewart Andrew Wayne | Director | 2022-06-06 | 2022-11-01 |
| LAUGHTON, Jonathan James | Director | 2010-11-19 | 2014-08-01 |
| LIPPOLDT, Darin Michael | Director | 2022-11-01 | 2026-01-21 |
| LLOYD-SMITH, Malcolm Charles | Director | 2022-11-01 | 2023-04-19 |
| PORTER, John Rendall | Director | 2022-06-06 | 2022-11-15 |
| RAYMOND, Alan Michael, Dr | Director | 2015-04-22 | 2016-03-23 |
| ROSS, Richard John Martin, Professor | Director | 2004-09-29 | 2022-11-01 |
| SCOTT, Michael | Director | 2022-06-06 | 2022-11-10 |
| TUCKER, Geoffrey Thomas, Dr | Director | 2010-11-23 | 2014-08-01 |
| WHITAKER, Martin James, Dr | Director | 2012-08-22 | 2022-04-04 |
| WILLIAMS, Samuel Cameron | Director | 2014-10-29 | 2016-03-23 |
| IP2IPO SERVICES LIMITED | Corporate Director | 2014-10-29 | 2015-12-03 |
| YORK PLACE COMPANY NOMINEES LIMITED | Corporate Nominee Director | 2004-09-21 | 2004-09-29 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Immedica Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 176 total filings
Material constitutional events — rename, articles re-file, resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-31 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-02-09 | CERTNM | change-of-name | Certificate change of name company | |
| 2026-01-28 | RP01SH01 | miscellaneous | Legacy | |
| 2026-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-27 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-27 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-09 | RESOLUTIONS | resolution | Resolution | |
| 2026-01-05 | SH01 | capital | Capital allotment shares | |
| 2025-09-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-07 | AA | accounts | Accounts with accounts type full | |
| 2024-10-21 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-10-21 | CERTNM | change-of-name | Certificate change of name company | |
| 2024-10-01 | AD03 | address | Move registers to sail company with new address | |
| 2024-10-01 | AD02 | address | Change sail address company with old address new address | |
| 2024-09-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-09-25 | CH01 | officers | Change person director company with change date | |
| 2024-05-29 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 13
- Capital events
- 1
- Officers appointed
- 3
- Officers resigned
- 3
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+28.5%
£12,885,000 £16,553,000
-
Cash
+100.1%
£3,262,000 £6,527,000
-
Net assets
-189.9%
-£5,116,000 -£14,830,000
-
Employees
+7.9%
38 41
-
Operating profit
+53%
-£17,448,000 -£8,203,000
-
Profit before tax
+45.5%
-£17,664,000 -£9,629,000
-
Wages
+18.4%
£4,817,000 £5,703,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers